Stefania De Lisi

Plain English
This study compared how well artificial intelligence (AI) systems, like ChatGPT, can determine when an esophagogastroduodenoscopy (a type of medical procedure) is necessary, compared to human doctors. In a survey with 135 healthcare professionals, AI accuracy ranged from 50% to 90% in April and dropped to 63% to 80% in September, with the AI versions ChatGPT-4.0 and ChatGPT-4.5 doing better than the doctors in September. This matters because it shows that AI can sometimes make better calls than doctors about medical procedures, but its performance can vary over time, so further testing is needed before it can be used in real-world settings. Who this helps: This helps patients needing accurate assessments for medical procedures.

Plain English
This study looked at endoscopic nasobiliary drainage (ENBD), a procedure used to relieve blockages in the bile ducts caused by various medical conditions. Researchers found that ENBD allows doctors to monitor bile output and collect samples more effectively, although it can cause discomfort for patients and requires careful handling to avoid complications. This research highlights the benefits of ENBD over other methods and proposes improvements to make the procedure easier and safer for patients. Who this helps: Patients with bile duct blockages.

Plain English
This study looked at how endoscopic ultrasonography (EUS) is being improved and used for diagnosing and treating diseases in the digestive system, particularly cancers. Recent advancements, such as better devices for taking tissue samples and techniques for draining fluid collections, have made EUS more accurate and less invasive. Notably, EUS-guided confocal laser endomicroscopy shows promise for diagnosing lesions in real time. Who this helps: Patients with gastrointestinal diseases, especially those with tumors, will benefit from these less invasive diagnostic and treatment options.

Plain English
This study looked at the role of a genetic marker called Interferon lambda-3 (IFN-λ3) in patients with liver cirrhosis caused by the hepatitis C virus. The researchers found that only 21% of patients overall achieved a sustained viral response after treatment, with those having the CC genotype seeing better results (40%) compared to others (just 10% and 13% for CT and TT genotypes, respectively). However, the IFN-λ3 genotype did not help predict how the liver disease would progress over time, which means it’s useful for treatment decisions but not for predicting outcomes. Who this helps: This helps doctors determine treatment options for patients with hepatitis C-induced cirrhosis.

Plain English
This study looked at a new method called confocal laser endomicroscopy to help doctors diagnose Barrett's oesophagus, a condition that can lead to cancer. Out of 50 patients examined, 48 underwent the new procedure, and it accurately predicted cancerous changes in tissue 98.1% of the time. This method could greatly improve how doctors screen for and monitor Barrett's oesophagus, allowing for faster and more precise diagnoses. Who this helps: This benefits patients at risk for Barrett's oesophagus and their doctors.

Plain English
Researchers studied the use of a procedure called oesophagogastroduodenoscopy in patients with liver cirrhosis to see what problems it could find beyond just high blood pressure in the liver. They found that 232 out of 611 patients (about 38%) had issues unrelated to liver pressure, including peptic diseases in 193 patients and other conditions in nearly 40% of those being screened. This is important because it shows that many cirrhosis patients might have additional health issues that need treatment, which could change their medical care plans. Who this helps: This helps patients with cirrhosis by ensuring they receive comprehensive check-ups for possible additional health problems.

Plain English
This study compared two medical procedures—endoscopic ultrasonography (EUS) and endoscopic retrograde cholangiopancreatography (ERCP)—for treating acute biliary pancreatitis, a serious condition caused by blocked bile ducts. The researchers looked at data from seven studies involving 545 patients and found that EUS was able to avoid unnecessary ERCP in 71.2% of cases, with no complications, while ERCP had a complication rate of up to 22% from bleeding. This matters because using EUS first can reduce risks and unnecessary procedures for patients with suspected bile duct stones. Who this helps: Patients with acute biliary pancreatitis.

Plain English
This study examined how endoscopic ultrasonography (a specialized imaging technique) can detect and help manage autoimmune pancreatitis (AIP), a condition where the body's immune system attacks the pancreas. The research highlighted that this imaging tool is effective in identifying the unique features of AIP and plays an important role in treatment decisions. Understanding these findings can lead to better diagnoses and care for patients with this challenging condition. Who this helps: Patients with autoimmune pancreatitis and their doctors.

Plain English
This study focused on autoimmune pancreatitis, a condition that can look very similar to pancreatic cancer, which makes it hard for doctors to tell them apart. The researchers found that while both conditions share many features, autoimmune pancreatitis can be treated effectively with steroids, helping patients avoid unnecessary surgery. It’s crucial for doctors to be familiar with this disease so they can provide the right care and improve patient outcomes. Who this helps: This benefits patients suffering from pancreatitis and healthcare providers diagnosing and treating these conditions.

Plain English
This study looked at seven patients with autoimmune pancreatitis, which can appear similar to pancreatic cancer on imaging tests. Researchers identified key features on endoscopic ultrasounds that help distinguish autoimmune pancreatitis from cancer, especially the confusing signs that could lead to misdiagnosis. Understanding these differences is important because it can prevent unnecessary treatments for patients who don’t have cancer. Who this helps: This helps doctors and patients by improving diagnosis accuracy.

Plain English
This study looks at how endoscopic ultrasonography, a special imaging technique, is used in diagnosing and treating portal hypertension, a condition caused by increased blood pressure in the liver's blood vessels. The researchers found that while this technique is very effective for various medical tasks, its specific role in managing portal hypertension is unclear. Understanding this is important as it could help doctors decide better treatment strategies for patients with this condition. Who this helps: This helps doctors who manage patients with portal hypertension.

Plain English
This study examined how factors like insulin resistance, certain proteins in the blood, and belly fat affect liver damage in patients with chronic hepatitis C. Researchers found that older age, higher insulin levels, and active liver inflammation were linked to more fat in the liver, while active inflammation and fat in the liver were connected to liver scarring. Additionally, 62.5% of patients responded well to antiviral treatment, and factors like being younger and not having belly fat improved treatment success. Who this helps: This research benefits patients with chronic hepatitis C and their doctors by improving understanding of factors affecting liver health and treatment outcomes.

Plain English
This study looked at whether patients with abnormal liver tests also have coeliac disease, which is a condition where the body reacts to gluten. Out of over 2,500 patients studied, only 6 (about 3.6%) were found to actually have coeliac disease after further testing, despite 20 showing positive markers for the condition. This matters because it highlights the importance of careful screening and testing, as coeliac disease is not common in these patients, and doctors need to know when to investigate further. Who this helps: This helps doctors in accurately diagnosing patients with abnormal liver tests.